T20QoL: An observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy

R. Bucciardini, M. Massella, A. Corpolongo, P. Narciso, V. Fragola, M. Mirra, S. Donnini, O. Viganò, S. Costarelli, V. Tozzi

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: To evaluate the impact of health-related quality of life (HRQoL) enfuvirtide-based (ENF-based) salvage regimens of treatment-experienced HIV patients, in an observational multicenter cohort study. Methods: HRQoL was measured in a cohort of 16 patients over a 6-month follow-up using 2 instruments: the ISSQoL (Istituto Superiore di Sanità Quality of Life), a recently validated HIV-specific questionnaire; the EQ-5D (EuroQol), a generic widely used instrument. ENF was given at standard dosage along with an optimized background regimen. Results: Most of HRQoL dimensions showed improvement in ENF-treated patients at the post-baseline time points. Social functioning was the only dimension showing a negative effect. Monthly care costs of antiretroviral drugs for HIV patients taking ENF plus an optimized background regimen were approximately €2,348 per patient-month (range €382-€2,940). Conclusion: Our results show that the addition of ENF to an optimized background salvage-HAART may positively affect HRQoL not only in clinical trials but also in a sample population of patients used in a routine clinical practice.

Original languageEnglish
Pages (from-to)577-581
Number of pages5
JournalBiologics: Targets and Therapy
Volume2
Issue number3
Publication statusPublished - 2008

Keywords

  • Enfuvirtide
  • HIV
  • HRQoL

ASJC Scopus subject areas

  • Oncology
  • Immunology and Allergy
  • Pharmacology (medical)
  • Gastroenterology
  • Rheumatology

Fingerprint Dive into the research topics of 'T20QoL: An observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy'. Together they form a unique fingerprint.

Cite this